FDA approvals—July 11-12, 2016
On July 12, the Food and Drug Administration (FDA) approved Xiidra (lifitegrast ophthalmic solution) for the treatment of signs and…
Please share your feedback! We’re interested to learn more about your experience with American Nurse Journal.